ACADIA Pharmaceuticals
ACAD
$15.21
Share price
-11.21%
Change (1 day)
-29.02%
Change (1 year)
Categories
ACADIA Pharmaceuticals (ACAD) - Cash on Hand
Cash on Hand as of December 2023 : $0.43 B
According to ACADIA Pharmaceuticals's latest financial reports the company has $0.43 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
ACADIA Pharmaceuticals - Cash on Hand chart (from 2003 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.43 B | 5.29% |
| 2022-12-31 | $0.41 B | -19.95% |
| 2021-12-31 | $0.52 B | -17.6% |
| 2020-12-31 | $0.63 B | -9.39% |
| 2019-12-31 | $0.69 B | 47.29% |
| 2018-12-31 | $0.47 B | 38.72% |
| 2017-12-31 | $0.34 B | -35.48% |
| 2016-12-31 | $0.52 B | 145.91% |
| 2015-12-31 | $0.21 B | -33.29% |
| 2014-12-31 | $0.32 B | 73.58% |
| 2013-12-31 | $0.18 B | 72.08% |
| 2012-12-31 | $0.10 B | 247.74% |
| 2011-12-31 | $31.04 M | -16.28% |
| 2010-12-31 | $37.08 M | -21.19% |
| 2009-12-31 | $47.06 M | -21.68% |
| 2008-12-31 | $60.08 M | -52.64% |
| 2007-12-31 | $0.12 B | 52.37% |
| 2006-12-31 | $83.25 M | 93.61% |
| 2005-12-31 | $43 M | 19.69% |
| 2004-12-31 | $35.92 M | 32.02% |
| 2003-12-31 | $27.21 M | 118.78% |
| 2002-12-31 | $12.43 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $26.21 B | 5,874.05% | 🇺🇸 USA |
 Pfizer PFE | $12.69 B | 2,791.55% | 🇺🇸 USA |
 Eli Lilly LLY | $2.58 B | 489.32% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $9.67 B | 2,103.41% | 🇺🇸 USA |
 Vanda Pharmaceuticals VNDA | $0.38 B | -11.53% | 🇺🇸 USA |
 Adamas Pharmaceuticals
ADMS | N/A | N/A | 🇺🇸 USA |